About: Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 1999

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1999 (uk) article scientifique publié en 1999 (fr) im Februar 1999 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 1999 (ast) artikull shkencor i botuar më 01 shkurt 1999 (sq) scientific article published on 01 February 1999 (en) գիտական հոդված հրատարակված 1999 թվականի փետրվարի 1-ին (hy)
publication date	wds:Q77379029-AB47E760-9EAD-4B3D-8065-E2CACBBE58A1
publication date	1999-02-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q77379029-13F85206-7FA1-4C67-A7B5-52CF63F810B0 wds:Q77379029-2BA6C057-DF22-42D0-ACAD-65A937C2A4E8 wds:Q77379029-420F5246-4C33-4F16-918B-91EBB6F2692C wds:Q77379029-42F9B510-43D9-4467-AC3E-7757BC27C086 wds:Q77379029-51FD5BDA-3843-4689-A3A4-D9361A06AA49 wds:Q77379029-58AEE1D0-7321-4E1E-AD97-7018FA1A99FA wds:Q77379029-5A0AD57E-47C4-4244-8533-239CC15844AF wds:Q77379029-5CDCD43C-E907-4CE6-84E9-E15216CA842A wds:Q77379029-6D925899-F002-4BE9-A5D2-A61AB4C8867F wds:Q77379029-75B3F9E6-2AFA-4617-9F75-199A1A70F62A wds:Q77379029-8A538C6E-25C6-4655-AAAC-0A5DB25B1570 wds:Q77379029-8E190BA2-F527-4AFB-ADA8-5C5C715E93EA wds:Q77379029-9268A665-525E-4593-97C7-17475968B372 wds:Q77379029-A4428B4A-436E-45E1-977E-16BDCEFCC2AD wds:Q77379029-B1EECF22-3D6D-4D24-8139-7962B5496933 wds:Q77379029-B6DFFF7A-BA6C-4EFF-A922-69FEC9229F8E wds:Q77379029-BE149637-357B-4A1C-9513-36008B630DF0 wds:Q77379029-BF961855-4786-427D-98B3-7BA7ACA42A32 wds:Q77379029-C3C013BC-0558-40FA-BFDA-D862D920391E wds:Q77379029-C7E759C6-7124-4BCD-B3AF-B115DA8D77E2 wds:Q77379029-D0FA95F1-C26B-4CA5-B14F-80FB945DAE0F wds:Q77379029-D5492E86-8975-4A9A-A4C5-7D30834821F4 wds:Q77379029-D7C7986A-0CD5-42C1-BB4F-966AF9613D86 wds:Q77379029-DAB90334-C4B6-40B2-B796-86827FA5F299 wds:Q77379029-E2DDED48-ED9C-401A-8C0C-8F23DE4FB2AF wds:Q77379029-E468452A-AEB4-4109-960E-7FD9E66CB82A wds:Q77379029-EA2164CA-EA8F-452E-B794-DC49A1D2873E wds:Q77379029-EFA1E7FE-F3A5-4459-B554-551861E7535B wds:Q77379029-F0B88084-0639-40FF-BBF0-33A3227D0A67 wds:Q77379029-F66A6336-384F-48F7-899D-D48A08F30E25 wds:Q77379029-FFEBCA7A-CD23-4CAD-8522-4C8EB5D38FA8
cites work	Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Cytokines, modified lipoproteins, and arteriosclerosis in diabetes Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM. Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells Relationships between plasma measures of oxidative stress and metabolic control in NIDDM Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros Minimally modified low density lipoprotein stimulates monocyte endothelial interactions A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION Hypercholesterolemia increases endothelial superoxide anion production Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells Oxidative stress and diabetic vascular complications Lipid advanced glycosylation: pathway for lipid oxidation in vivo Low density lipoprotein undergoes oxidative modification in vivo Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2 Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression. Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals Probucol inhibits oxidative modification of low density lipoprotein Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells Probucol reduces plasma lipid peroxides in man
author name string	wds:Q77379029-167E0B4E-0066-4A15-8738-130DB45CC74B wds:Q77379029-591DA6BF-B36B-4DAB-A522-A1CC131B64E8 wds:Q77379029-6D9D6173-38C8-452D-BCFD-C2002F0BEF79 wds:Q77379029-92EAC538-4D2D-415B-B728-27B1640D6139
author name string	Y Nishio N Harada A Kashiwagi R Kikkawa
rdfs:label	Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients (en) Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients (nl) Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients (sq)
skos:prefLabel	Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients (en) Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients (nl) Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients (sq)
name	Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients (en) Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients (nl) Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients (sq)
title	wds:Q77379029-284D63CA-8726-4022-999C-9A39AB8F44BE
title	Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients (en)
page(s)	wds:Q77379029-8ECF506D-AEC4-4F8F-A003-83DDD7D60AFD
page(s)	111-120
instance of	wds:Q77379029-6EFD1662-AF7A-4B21-9407-33A6838B6C63
instance of	scholarly article
PubMed ID	wds:Q77379029-6946CBF5-1D5C-4E2F-B855-12AF2E9B56EC
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10221663
PubMed ID	10221663
published in	wds:Q77379029-27E38FB7-9FE7-45E9-B621-53C5744B49CA

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software